Journal retracts nine papers in one day by author under investigation at the Weizmann Institute

On April 27, the Journal of Biological Chemistry (JBC) retracted nine papers by a researcher based in Israel, including some dating back to 2000. The reason: Image manipulation. Michal Neeman, vice president of The Weizmann Institute of Science, told us that the researcher, Rony Seger, is under investigation following an allegation of misconduct affecting papers in multiple … Continue reading Journal retracts nine papers in one day by author under investigation at the Weizmann Institute

Paper by Harvard cancer biologist flagged over “credible concerns”

A cancer biologist at Harvard who’s issued multiple editorial notices in recent years has received an expression of concern about a 2011 paper, citing “credible concerns” with the data and conclusions. The publisher does not detail the nature of the issues in the notice. In the past few years, last author Sam W. Lee lost a Molecular Cell paper in 2013 due to figure … Continue reading Paper by Harvard cancer biologist flagged over “credible concerns”

Author objects to retraction after he says journal ignored his queries for three years

In 2014, a journal contacted researcher Denis Rousseau about one of his papers that had just been published online ahead of print, raising some concerns. According to Rousseau, he sent the journal a corrected figure “almost immediately,” which he believed addressed the issue. Rousseau, a cell biologist at the University Joseph Fourier in Grenoble, France, said he then contacted the journal many … Continue reading Author objects to retraction after he says journal ignored his queries for three years

University suggests journal correct diabetes paper. Publisher retracts it.

After a publisher learned there may be issues with a 2008 diabetes paper, it asked the author’s university to investigate. The university found evidence of image duplication, and asked the journal to consider correcting the paper. Instead, the journal has retracted it. The backstory involves diabetes researcher Kathrin Maedler, who has one previous retraction, as … Continue reading University suggests journal correct diabetes paper. Publisher retracts it.

Former rising star found guilty of misconduct issues 2nd retraction

A once-lauded researcher in the field of infectious disease — who has since been found guilty of misconduct — has retracted a second paper. Last year, the University of Dundee in Scotland investigated and ultimately concluded that Robert Ryan — whose work focused on infections that can be deadly in people with lung diseases such as cystic fibrosis … Continue reading Former rising star found guilty of misconduct issues 2nd retraction

Harvard diabetes researcher retracts third paper

A prominent diabetes researcher based at Harvard Medical School has retracted a third paper, citing manipulation of multiple figures. Late last year, Carl Ronald Kahn—also chief academic officer at Joslin Diabetes Center—retracted two papers for similar reasons. In November, Kahn pulled a 2005 paper from The Journal of Clinical Investigation (JCI) and a month later, he retracted a 2003 paper from The … Continue reading Harvard diabetes researcher retracts third paper

Plant biologist earns string of retractions, bringing total to 9

A pair of plant biologists has lost a string of papers over concerns about image manipulation. One author has added eight new retractions to his CV; the other has added five. Last summer, a journal retracted another paper by the pair, also citing suspicions of image manipulation. The latest batch of retractions — issued by seven … Continue reading Plant biologist earns string of retractions, bringing total to 9

Fired Pfizer cancer researcher loses final two of five papers pegged for retraction

PLOS ONE has retracted the last of five papers by a former employee of Pfizer, who the company fired after determining she had duplicated data. After its investigation, Pfizer asked journals to retract five papers co-authored by Min-Jean Yin. Last week, PLOS ONE retracted the final two remaining papers. Both notices cite image duplications; Yin contacted the … Continue reading Fired Pfizer cancer researcher loses final two of five papers pegged for retraction

As third retraction for prominent physicist appears, university still won’t acknowledge investigation

Despite a university’s attempts to avoid discussing a misconduct investigation involving one of its former (and prominent) researchers, we keep reading more about it. In the third retraction this year for physicist Dmitri Lapotko, the journal mentions a misconduct investigation at Rice University, which concluded the data had been falsified. Trouble is, whenever we’ve tried to talk … Continue reading As third retraction for prominent physicist appears, university still won’t acknowledge investigation

Three figures in blood pressure paper were manipulated, says journal

A pharmacology journal has retracted a 2011 paper after concluding images in three figures had been manipulated. According to the British Journal of Pharmacology, four of the five authors claim they played no role in the manipulation. There is no comment from the remaining author, first author Ian Morecroft, a research associate at the University of … Continue reading Three figures in blood pressure paper were manipulated, says journal